Sarissa Capital Acquisition Corp. today announced the pricing of its initial public offering of 17,500,000 units, at a price of $10.00 per unit. The Company's sponsor, Sarissa Capital Acquisition Sponsor LLC, was capitalized by investment funds managed by Sarissa Capital Management LP, which was founded by Alex Denner, Ph.D.

The units will be listed on The Nasdaq Capital Market (the "Nasdaq") and will trade under the ticker symbol "SRSAU" beginning on October 21, 2020. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share. After the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be listed on the Nasdaq under the symbols "SRSA" and "SRSAW," respectively. The offering is expected to close on October 23, 2020.

The Company is a new blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the "Initial Business Combination"). While the Company may pursue an acquisition opportunity in any industry or sector, it intends to focus on the healthcare industry in the United States and other developed countries.

Cantor Fitzgerald & Co. ("Cantor") is acting as sole book-running manager for the offering. The Company has granted Cantor a 45-day option from the date of the final prospectus to purchase up to an additional 2,625,000 units to cover over-allotments, if any.